AGT launches two new APH wheat varieties to give northern growers more planting and rotational flexibility
Australian Grain Technologies (AGT) has launched two new Australian Premium Hard (APH) wheat varieties, AGT-Agile and AG…
ClearLeaf expands to Guatemala with new product registration
ClearLeaf, a Costa Rican agtech leader specializing in sustainable, non-toxic crop protection, today announced it has of…
杭州2026年度农机修理与操作技能提升专题培训班在桐庐举办
为进一步提升全市农机修理从业人员专业技能与实操业务水平，规范农机安全操作管理，夯实农业机械化与现代化发展的坚实根基，9月10日至11日，浙江省杭州市2026年度农机修理及操作技能提升培训班在桐庐县举办。本次培训由杭州市农业执法监督指导中…
敦煌开展秋收农机安全生产及农机补贴政策专题业务辅导培训
为持续增强“三秋”农机生产作业服务保障能力，确保全年农业丰收和农民增收，近日，甘肃省酒泉市敦煌市农业机械服务中心组织全市8个乡镇农业农村综合服务中心农机专干，3家农机报废企业负责人、一线工作人员，针对秋季农机安全…
“主会场＋分会场”联动：湖北农机鉴定站联合三社区举办科普讲座
9月8日上午，“生物育种与你我生活”科普讲座在湖北工业大学博学堂举办。本次讲座采取“主会场+分会场”联动模式，主会场设于湖北工业大学，面向在校师生线下开展；武南铁路社区、湖工社区、张家湾社…
Exosomes Linked to Nerve Irritation, Dysfunction, and Lingering Pain After Shingles
The results of a study by researchers at the University of Colorado Anschutz suggest that that extracellular vesicles known as exosomes in the blood are the likely culprit behind why some people with shingles experience lingering pain—post-herpetic neuralgia (PHN)—long after the causative varicella zoster virus (VZV) has cleared the body.
Digital ag platform xFarm Technologies expands to sugarcane, biofuels with Sibium Analytics acquisition
Swiss agtech company xFarm Technologies has acquired Brazilian agtech platform Sibium Analytics, which provides geospati…
dsm-firmenich and Estée Lauder advance AI-driven beauty discoveries
Beauty companies are increasingly shifting AI strategies from operational efficiency toward discovery and personalization. dsm-firmenich is applying AI to ingredient discovery through its partnership with Boltz, while The Estée Lauder Companies (ELC) is using AI-powered insights through Profound to optimize brand visibility across generative search platforms.
ResoTher heart data clear acquisition hurdle, set up 200-patient trial
Why it matters: RTP-026 is the first drug based on annexin A1, one of the body’s own brakes on inflammation, to be tested in heart attack patients. Three decades of trials to limit infarct size have been “disappointingly neutral,” an August review concluded.
Puig takes control of Isdin in US$1.4B dermocosmetics deal
Puig has agreed to acquire Corporación Químico-Farmacéutica Esteve’s remaining 50% interest in Isdin for €1.2 billion (US$1.41 billion), positioning the Spanish beauty group to take full control of the dermatology-focused skin care business.